Highlights
• Courtesy of WHO's decision, poor countries are likely to get access to the vaccine which is currently available in the North America and Europe
• This decision by WHO opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine
• The global body also said that as per its review, the Pfizer-BioNTech vaccine met the must-have cr....
Tags : WHO, COVID-19 vaccine, Pfizer, BioNTech, ,
comments (0)